#RSNA14: Primary Physicians Not Well Informed about Breast Density
The California law, effective April 2013, includes a prescribed lay letter, which suggests discussing with their doctor the results of their mammogram and the screening options
Their electronic survey set out to investigate primary care physician awareness of the California Breast Density Notification Law and its impact on primary care practice, and was sent to 174 outpatient physicians. Questions covered awareness, perceived changes in levels of concern and comfort levels in dealing with these issues.
Nearly half of the respondent physicians (48%) said they were rarely asked about breast density, while 20% said never. Thirty-two percent noted a change in patient concern about the issue. Most were asked about getting additional screening tests because of breast density (51%), effectiveness of mammograms in dense breasts (49%) or risk of breast cancer due to dense breasts (41%). Less than one-third said they were comfortable to answer questions about breast density. Most were either “somewhat comfortable” or “not comfortable” to answer questions. Encouragingly, 75% were interested in additional background education. Twenty percent of physicians reported they had ordered supplementary screening tests for women with dense breasts who had no other breast cancer risk factors. Of those that ordered additional testing, 44% ordered Breast MRI, 22% ordered whole breast ultrasound, 11% ordered tomosynthesis, and 22% ordered other unspecified testing.
There were statistically significant differences between genders (53% of the respondents were female). Nineteen percent of males and 43% of females perceived changes in patients’ concern. Khong noted the limitations of the study being from a single academic medical centre, which has a specialty Breast Health Clinic and a dedicated breast density website linked to their electronic medical record (breastdensity.info). In addition there may be physician recall bias.
Khong concluded that enactment of breast density notification laws without providing adequate primary physician education and resources is unlikely to significantly impact patient care. Increased patient awareness will be effective only if physicians have sufficient knowledge to advise patients regarding their risk of breast cancer aand the advisability of supplemental screening. The California law will either expire or be renewed in 2019 so awareness needs to increase.
Asked by a physician from New Hampshire, which does not have legislation how to go about proactively education physicians, she recommended the resource breastdensity.info resource, which has information for radiologists, general physicians and for patients, including prepared lectures and brochures.
Managing Editor, HealthManagement
Published on : Thu, 4 Dec 2014
UltraDrape is an innovative dressing designed for use during Ultrasound-Guided Peripheral Intravenous (UGPIV) that provides dual-action barrier and securement in one.
THE VEVO MD IS THE WORLD’S FIRST ULTRA HIGH FREQUENCY ULTRASOUND SYSTEM DESIGNED FOR CLINICAL USE WITH FREQUENCIES UP TO 70 MHz. This groundbreaking technology opens up new possibilities for medical imaging that have never been seen before. Whether...
Sectra's reporting module, developed with complex oncology cases in mind, facilitates overview of relevant priors together with the current request and report text. It also offers support for resident workflows and embedded links to images in the rep...
The SonoSite EDGE II is a high-resolution, all-digital, 9.0-pound (4.1 kg) ultrasound system with a 12.1in. LED full-bleed glass display. The Edge II boosts improvements in cardiac and abdominal image quality through DirectClear Technology and a new...
The TE7 touch screen ultrasound system is designed to provide superior quality imaging for rapid patient-care decisions. Intuitive gesture controls and efficient focused point-of-care exams minimize the user learning curve, with no need to navigate a...